Treatment of Non Alcoholic Fatty Liver Disease With Lifestyle Modification and Acupuncture
NCT02006329 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2013-12-10
Summary
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver dysfunction worldwide. NAFLD may progress to nonalcoholic steatohepatitis (NASH) and in turn to cirrhosis. To date, the detailed pathogenic mechanism of NAFLD including steatosis and NASH is not fully characterized, although it is regarded as a hepatic manifestation of the metabolic syndrome, sometimes it occurs in the absence of a metabolic syndrome. Based on conventional models of "two-hit" and "multi- hit" hypothesis of NAFLD, the dysregulated lipid metabolism and insulin resistance are considered as the "first hit" of the liver and the following "second hit" or "multi-hit" likely involves oxidative stress, lipid peroxidation, increased inflammatory responses, induced hepatic fibrosis and apoptosis. This emphasizes the multi-factorial pathogenesis of NAFLD and the necessity to treat NAFLD with diabetes-like and multimodal strategy. Several changes in dietary intake have occurred in the past few years, including increased energy intake (24%), and increases in added sugars, flour and cereal products, fruit, added fats and total fat intake. The increasing prevalence of NAFLD is probably directly affected by the contemporary epidemics of obesity, unhealthy dietary pattern, and sedentary lifestyle. Currently, there are two major categories of NAFLD therapy: lifestyle interventions and pharmaceutical therapies, lifestyle interventions in terms of diet and physical activity are regarded as safe and effective, while pharmaceutical interventions showed limited efficacy with unknown safety in the long term ,therefore, the first line of treatment is lifestyle modification. Although lifestyle intervention dose positively affects NAFLD, it has limitations. Patients adherence to dietary intervention is 50%, while those who do adhere, find it difficult to maintain after 12 months. ). Mediterranean diet has been shown to be effective in reducing NAFLD, liver steatosis and improve insulin sensitivity. Acupuncture has been found as an effective treatment for improving quality of life in various medical conditions , including hepatitis . Acupuncture combined with life style intervention has been found effective in the treatment of obesity, metabolic syndrome in terms of weight, lipid regulation, glucose levels and various markers of inflammation. Acupuncture's effect on NAFLD has yet to be studied.
We suggest that acupuncture combined with life style intervention can be an effective treatment for NAFLD.
Conditions
- NAFLD
- Accupuncture
Interventions
- DEVICE
-
acupuncture
Sponsors & Collaborators
-
Ziv Hospital
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2014-11-30
Countries
- Israel
Study Locations
More Related Trials
-
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
NCT06836609 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees
NCT06536933 ·Status: NOT_YET_RECRUITING
-
Non Alcoholic Fatty Liver Disease Influence of Statin Therapy
NCT00375349 ·Status: WITHDRAWN ·Phase: NA
-
Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients
NCT06503068 ·Status: RECRUITING
-
Manual Therapy in Metabolic Liver Disease
NCT06338618 ·Status: COMPLETED ·Phase: NA
-
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
NCT01987310 ·Status: WITHDRAWN ·Phase: NA
-
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
NCT04454463 ·Status: COMPLETED
-
Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD
NCT06321211 ·Status: COMPLETED
-
Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity
NCT06446908 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Nonalcoholic Steatohepatitis in Chinese Children
NCT03190538 ·Status: RECRUITING
-
Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver Cirrhosis
NCT01412593 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease
NCT02217345 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease
NCT02927314 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar
NCT06193629 ·Status: RECRUITING ·Phase: NA
-
Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial
NCT06798948 ·Status: RECRUITING ·Phase: PHASE2
-
Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells
NCT00913289 ·Status: TERMINATED ·Phase: PHASE1
-
NAFLD and Liver Fibrosis in Obese Adolescents
NCT04561804 ·Status: COMPLETED
-
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
NCT06913699 ·Status: ACTIVE_NOT_RECRUITING
-
Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD).
NCT05946330 ·Status: UNKNOWN ·Phase: NA
-
Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)
NCT03613480 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Dihydromiricetin on MASLD
NCT05052515 ·Status: COMPLETED ·Phase: NA
-
Treating Nonalcoholic Steatohepatitis (NASH) With Metformin
NCT00063232 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects
NCT05930093 ·Status: RECRUITING ·Phase: NA
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NCT06138821 ·Status: RECRUITING ·Phase: NA
-
Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study
NCT01791452 ·Status: UNKNOWN